Literature DB >> 21396211

The impact of previous tuberculosis history on T-SPOT.TB® interferon-gamma release assay results.

H-J Kim1, H I Yoon, K U Park, C-T Lee, J H Lee.   

Abstract

SETTING: Seoul National University Bundang Hospital, a tertiary referral hospital in Korea.
OBJECTIVE: To evaluate whether previous tuberculosis (TB) history has a long-term effect on T-SPOT.TB® results after anti-tuberculosis treatment.
DESIGN: We retrospectively reviewed 489 adults (age ≥18 years) who underwent T-SPOT.TB as part of their evaluation between January 2008 and July 2009.
RESULTS: Among 489 subjects analysed, 369 were finally included. Active TB was diagnosed in 121/369 (32.8%). T-SPOT.TB was positive in 110 (90.9%) active TB patients. Of the 248 subjects without active TB, T-SPOT.TB positivity was significantly different between the 51 patients with a previous TB history and the 197 without (84.3% vs. 26.9%, P < 0.001). The difference in T-SPOT.TB positivity between the 51 non-active TB patients with a TB history and the 121 active TB patients was not statistically significant (84.3% vs. 90.9%, P = 0.208). Among the 51 non-active TB individuals with a TB history, the mean time since anti-tuberculosis treatment was 22.7 years (range 1-59); this had no correlation with total region of difference 1 (RD1) spot-forming cells (r = -0.076, P = 0.597).
CONCLUSION: T-SPOT.TB has a limited role in the diagnosis of TB infection in individuals with a previous history of TB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396211     DOI: 10.5588/ijtld.10.0520

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease History.

Authors:  Thomas J Scriba; Chelsea Carpenter; Sebastian Carrasco Pro; John Sidney; Munyaradzi Musvosvi; Virginie Rozot; Grégory Seumois; Sandy L Rosales; Pandurangan Vijayanand; Delia Goletti; Edward Makgotlho; Willem Hanekom; Mark Hatherill; Bjoern Peters; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

2.  Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study.

Authors:  Seung Jun Lee; Seung Hun Lee; You Eun Kim; Yu Ji Cho; Yi Yeong Jeong; Ho Cheol Kim; Jong Deog Lee; Jang Rak Kim; Young Sil Hwang; Hee Jin Kim; Dick Menzies
Journal:  BMC Infect Dis       Date:  2014-11-18       Impact factor: 3.090

3.  PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.

Authors:  Shao-Bo Wang; Yun-Hai Ji; Hu-Bing Wu; Quan-Shi Wang; Wen-Lan Zhou; Liang Lv; Tao Shou; Jing Hu
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  Tuberculous spondylitis after vertebral augmentation: A case report with a literature review.

Authors:  Sun Jia-Jia; Sun Zhi-Yong; Qian Zhong-Lai; Yang Hui-Lin; Zhu Xiao-Yu
Journal:  J Int Med Res       Date:  2017-09-20       Impact factor: 1.671

5.  Factors associated with differential T cell responses to antigens ESAT-6 and CFP-10 in pulmonary tuberculosis patients.

Authors:  Shengsheng Liu; Meiying Wu; Ertai A; Shucai Wu; Shujun Geng; Zhihui Li; Mingwu Li; Liang Li; Yu Pang; Wanli Kang; Shenjie Tang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

6.  Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis.

Authors:  Jordan L Mitchell; Conor O'Halloran; Paul Stanley; Kieran McDonald; Paul Burr; Danièlle A Gunn-Moore; Jayne C Hope
Journal:  Pathogens       Date:  2021-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.